Form 4: Zimmer Biomet Executive Chad F. Phipps Reports Stock Transactions

Chad F. Phipps, Sr. VP/Gen Counsel/Secretary of Zimmer Biomet Holdings, Inc., reports the vesting and subsequent disposition of restricted stock units and other stock transactions.

Summary

• On February 18, 2025, Chad F. Phipps, a Senior VP/Gen Counsel/Secretary at Zimmer Biomet Holdings, Inc., engaged in transactions involving the company's common stock and restricted stock units (RSUs).
• Phipps acquired 10,158 shares of common stock upon the vesting of RSUs at a price of $0.
• Simultaneously, Phipps disposed of 2,552 shares to cover tax withholding obligations at a price of $101 per share.
• Following these transactions, Phipps directly owns 57,406 shares of Zimmer Biomet common stock.
• The transactions also involved the vesting of 10,158 performance-based RSUs, which were granted on February 18, 2022, and determined to be earned based on performance between 2022 and 2024.

Sentiment

Score: 6

Explanation: The document reflects standard insider transactions. The vesting of RSUs is a positive sign, but the sale for tax obligations is neutral. Overall, it's a routine filing with no major positive or negative implications.

Positives

• The vesting of RSUs indicates that performance conditions were met, which could be viewed positively.

Negatives

• The sale of shares to cover tax obligations could be seen as a slight dilution of holdings, although it's a common practice.

Risks

• There are no specific risks mentioned in this document.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions have a minor impact on shareholders due to the small number of shares involved.

Key Dates